Terms: = Thyroid cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
196 results:
1. Augmented ERO1α upon mTORC1 activation induces ferroptosis resistance and tumor progression via upregulation of SLC7A11.
Wang Z; Zong H; Liu W; Lin W; Sun A; Ding Z; Chen X; Wan X; Liu Y; Hu Z; Zhang H; Li H; Liu Y; Li D; Zhang S; Zha X
J Exp Clin Cancer Res; 2024 Apr; 43(1):112. PubMed ID: 38610018
[TBL] [Abstract] [Full Text] [Related]
2. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating stat3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract] [Full Text] [Related]
3. Hypoxia-induced miR-5100 promotes exosome-mediated activation of cancer-associated fibroblasts and metastasis of head and neck squamous cell carcinoma.
Duan Y; Zhou M; Ye B; Yue K; Qiao F; Wang Y; Lai Q; Wu Y; Cao J; Wu Y; Wang X; Jing C
Cell Death Dis; 2024 Mar; 15(3):215. PubMed ID: 38485986
[TBL] [Abstract] [Full Text] [Related]
4. K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.
Wang X; Deng X; Hu J; Zheng W; Ye D; Zhou X; Fang L
Cancer Lett; 2024 Apr; 588():216764. PubMed ID: 38431034
[TBL] [Abstract] [Full Text] [Related]
5. Sciellin promotes the development and progression of thyroid cancer through the JAK2/stat3 signaling pathway.
Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
[TBL] [Abstract] [Full Text] [Related]
6. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract] [Full Text] [Related]
7. Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission.
Guo YW; Zhu L; Duan YT; Hu YQ; Li LB; Fan WJ; Song FH; Cai YF; Liu YY; Zheng GW; Ge MH
Cell Death Dis; 2024 Feb; 15(2):125. PubMed ID: 38336839
[TBL] [Abstract] [Full Text] [Related]
8. IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/stat3 pathway.
Zhou M; Yu H; Bai M; Lu S; Wang C; Ke S; Huang J; Li Z; Xu Y; Yin B; Li X; Feng Z; Fu Y; Jiang H; Ma Y
Cancer Sci; 2024 Mar; 115(3):777-790. PubMed ID: 38228495
[TBL] [Abstract] [Full Text] [Related]
9. cancer incidence in Iran in 2016: A study based on the Iranian National cancer Registry.
Hadavandsiri F; Allahqoli L; Rahimi Y; Salehiniya H; Ghazanfari Savadkoohi E; Akbari ME
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1967. PubMed ID: 38148563
[TBL] [Abstract] [Full Text] [Related]
10. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.
Afaq F; Agarwal S; Bajpai P; Diffalha SA; Kim HG; Peter S; Khushman M; Chauhan SC; Mukherjee P; Varambally S; Manne U
Neoplasia; 2024 Jan; 47():100951. PubMed ID: 38039923
[TBL] [Abstract] [Full Text] [Related]
11. Oncogenic PIK3CA recruits myeloid-derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5-lipoxygenase-dependent arachidonic acid pathway.
Li X; Chen G; Wang F; Guo X; Zhang R; Liu P; Dong L; Yu W; Wang H; Wang H; Yu J
Clin Transl Med; 2023 Nov; 13(11):e1483. PubMed ID: 37965796
[TBL] [Abstract] [Full Text] [Related]
12. RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-stat3-CD24/MMPs axis.
Zhang FX; Xu P; Zhang LJ; Fan R; Zhang HX; Liu DH; Liu K; Shen DY
Int Immunopharmacol; 2023 Dec; 125(Pt A):111129. PubMed ID: 37897947
[TBL] [Abstract] [Full Text] [Related]
13. PRMT6 methylation of stat3 regulates tumor metastasis in breast cancer.
Chen Q; Hu Q; Chen Y; Shen N; Zhang N; Li A; Li L; Li J
Cell Death Dis; 2023 Oct; 14(10):655. PubMed ID: 37813837
[TBL] [Abstract] [Full Text] [Related]
14. Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation.
Yuan K; Hu D; Mo X; Zeng R; Wu B; Zhang Z; Hu R; Wang C
Aging (Albany NY); 2023 Sep; 15(17):8729-8743. PubMed ID: 37671970
[TBL] [Abstract] [Full Text] [Related]
15. Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer.
Hsu YC; Huang WC; Kuo CY; Li YS; Cheng SP
Mol Carcinog; 2023 Dec; 62(12):1935-1946. PubMed ID: 37642311
[TBL] [Abstract] [Full Text] [Related]
16. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
17. stat3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
18. Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.
Zhang GQ; Xi C; Shen CT; Song HJ; Luo QY; Qiu ZL
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37260320
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms.
Althagafy HS; El-Aziz MKA; Ibrahim IM; Abd-Alhameed EK; Hassanein EHM
Eur J Pharmacol; 2023 Jul; 951():175776. PubMed ID: 37192715
[TBL] [Abstract] [Full Text] [Related]
20. CAA-derived IL-6 induced M2 macrophage polarization by activating stat3.
Zhao C; Zeng N; Zhou X; Tan Y; Wang Y; Zhang J; Wu Y; Zhang Q
BMC Cancer; 2023 May; 23(1):392. PubMed ID: 37127625
[TBL] [Abstract] [Full Text] [Related]
[Next]
